Brussels: Ensuring access to safe and affordable covid-19 vaccines around the world, and notably for low and middle-income countries, is a priority for the European Union.
At the Global Health Summit in Rome this week, European Commission President Ursula von der Leyen announced that ‘Team Europe' would share with low and middle-income countries at least 100 million doses by the end of 2021, mainly via COVAX, our partner in vaccinating the world.
Team Europe (the EU, its institutions and all 27 Member States) is on track to exceed this initial goal, with 200 million doses of covid-19 vaccines foreseen to be shared with the countries that need them most, by the end of 2021.
"Team Europe takes its responsibility in helping the world fight the virus, everywhere. Vaccination is key – that's why it is essential to ensure access to covid-19 vaccines to countries worldwide. We will be sharing more than 200 million doses of COVID-19 vaccines with low and middle-income countries by the end of this year," said von der Leyen in a press release on Thursday.
The more than 200 million doses of COVID-19 vaccines that have been committed by Team Europe will reach their destination countries, mainly through COVAX, by the end of this year.
COVAX has so far delivered 122 million doses to 136 countries.
In parallel, Team Europe has launched an initiative on manufacturing and access to vaccines, medicines and health technologies in Africa.
The initiative will help create the right conditions for local vaccine manufacturing in Africa, backed by €1 billion from the EU budget and the European development finance institutions such as the European Investment Bank (EIB).
Cek Berita dan Artikel yang lain di Google News
FOLLOW US
Ikuti media sosial medcom.id dan dapatkan berbagai keuntungan
